Antonio La Cava1. 1. Department of Medicine, University of California Los Angeles, 1000 Veteran Avenue 32-59, Los Angeles, CA, 90095, USA. alacava@mednet.ucla.edu.
Abstract
PURPOSE OF REVIEW: There has been great interest in understanding why T regulatory cells (Tregs) are reduced in number and/or in function in several autoimmune diseases including systemic lupus erythematosus (SLE). Although research has provided some answers, there is still much to learn. RECENT FINDINGS: Recent investigations on the mechanisms responsible for the impairment of the Tregs in SLE have identified relevant abnormalities in cellular and molecular pathways that have been instrumental in the design of studies in animal models and in the development of pilot immunotherapeutic studies in lupus patients. We review the progress made in the field in the last 5 years, discussing the mechanistic studies, together with the preclinical and clinical works that are moving forward the understanding of the physiopathology of Tregs in SLE.
PURPOSE OF REVIEW: There has been great interest in understanding why T regulatory cells (Tregs) are reduced in number and/or in function in several autoimmune diseases including systemic lupus erythematosus (SLE). Although research has provided some answers, there is still much to learn. RECENT FINDINGS: Recent investigations on the mechanisms responsible for the impairment of the Tregs in SLE have identified relevant abnormalities in cellular and molecular pathways that have been instrumental in the design of studies in animal models and in the development of pilot immunotherapeutic studies in lupuspatients. We review the progress made in the field in the last 5 years, discussing the mechanistic studies, together with the preclinical and clinical works that are moving forward the understanding of the physiopathology of Tregs in SLE.
Authors: Angela M Thornton; Patricia E Korty; Dat Q Tran; Elizabeth A Wohlfert; Patrick E Murray; Yasmine Belkaid; Ethan M Shevach Journal: J Immunol Date: 2010-02-24 Impact factor: 5.422
Authors: Jens Y Humrich; Henner Morbach; Reinmar Undeutsch; Philipp Enghard; Stefan Rosenberger; Olivia Weigert; Lutz Kloke; Juliane Heimann; Timo Gaber; Susan Brandenburg; Alexander Scheffold; Jochen Huehn; Andreas Radbruch; Gerd-Rüdiger Burmester; Gabriela Riemekasten Journal: Proc Natl Acad Sci U S A Date: 2009-12-14 Impact factor: 11.205
Authors: Zhi-Wei Lai; Robert Hanczko; Eduardo Bonilla; Tiffany N Caza; Brandon Clair; Adam Bartos; Gabriella Miklossy; John Jimah; Edward Doherty; Hajra Tily; Lisa Francis; Ricardo Garcia; Maha Dawood; Jianghong Yu; Irene Ramos; Ioana Coman; Stephen V Faraone; Paul E Phillips; Andras Perl Journal: Arthritis Rheum Date: 2012-09
Authors: Wen Pan; Shu Zhu; Dai Dai; Zheng Liu; Dan Li; Bin Li; Nicola Gagliani; Yunjiang Zheng; Yuanjia Tang; Matthew T Weirauch; Xiaoting Chen; Wei Zhu; Yue Wang; Bo Chen; Youcun Qian; Yingxuan Chen; Jingyuan Fang; Ronald Herbst; Laura Richman; Bahija Jallal; John B Harley; Richard A Flavell; Yihong Yao; Nan Shen Journal: Nat Commun Date: 2015-05-12 Impact factor: 17.694
Authors: Michelle Schorer; Katharina Lambert; Nikolas Rakebrandt; Felix Rost; Kung-Chi Kao; Alexander Yermanos; Roman Spörri; Josua Oderbolz; Miro E Raeber; Christian W Keller; Jan D Lünemann; Gerhard Rogler; Onur Boyman; Annette Oxenius; Nicole Joller Journal: Nat Commun Date: 2020-03-23 Impact factor: 14.919
Authors: Ricardo C Ferreira; Xaquin Castro Dopico; João J Oliveira; Daniel B Rainbow; Jennie H Yang; Dominik Trzupek; Sarah A Todd; Mhairi McNeill; Maristella Steri; Valeria Orrù; Edoardo Fiorillo; Daniel J M Crouch; Marcin L Pekalski; Francesco Cucca; Tim I Tree; Tim J Vyse; Linda S Wicker; John A Todd Journal: Front Immunol Date: 2019-11-08 Impact factor: 7.561